Leukemia Myelomonocytic Chronic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2021-08-04
EMA Withdrawn: Azacitidine Celgene (azacitidine) — Celgene Europe BV
The EMA has withdrawn the azacitidine product Celgene Europe BV from the market.